Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study / G.M. Prati, A. Aghemo, L. Ronzoni, M.G. Rumi, S. Monico, A. Colancecco, P. Grillo, M. Viganò, M.D. Cappellini, M. Colombo. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1590-8658. - 41:Suppl. 1(2009 Mar), pp. S51-S51. ((Intervento presentato al 15. convegno National congress of Digestive Disease - Italian Federation of Societies of Digestive Diseases FISMAD tenutosi a Milano nel 2009 [10.1016/S1590-8658(09)60131-6].
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study
G.M. PratiPrimo
;A. Aghemo;L. Ronzoni;M.G. Rumi;S. Monico;A. Colancecco;P. Grillo;M. Viganò;M.D. Cappellini;M. Colombo
2009
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1590865809601316-main.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
74.43 kB
Formato
Adobe PDF
|
74.43 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
